DOG1 utility in diagnosing gastrointestinal stromal tumors on fine-needle aspiration

Cancer Cytopathology

Volumn 119, Issue 3, 2011, Pages 202-208

  Fatima, Nazneen ^a   Cohen, Cynthia ^a   Siddiqui, Momin T ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Cell blocks; DOG 1; Fine needle aspiration; GIST; Immunohistochemistry

Indexed keywords

CHLORIDE CHANNEL; DISCOVERED ON GIST 1 PROTEIN; PROTEIN KINASE C THETA; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; ANO1 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR PROTEIN;

ADENOID CYSTIC CARCINOMA; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FINE NEEDLE ASPIRATION BIOPSY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MELANOMA; NEURILEMOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SPINDLE CELL CARCINOMA; GENETICS; NEEDLE BIOPSY; PATHOLOGY;

BIOPSY, NEEDLE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NEOPLASM PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 80051660391     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20149     Document Type: Article

References (31)

1. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152:1259-1269.
2. Reith JD, Goldblum JR, Lyles RH, Weiss SW. Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs). Mod Pathol. 2000;13:577-585.
3. Weiss SW, Goldblum JR. Extragastrointestinal stromal tumors. In: Soft Tissue Tumors. 5th ed. Philadelphia, PA: Mosby Elsevier; 2008:565-581.
4. Montgomery E, Fisher C. Gastrointestinal mesenchymal tumors. In: Goldblum Jr. Gastrointestinal and Liver Pathology. 1st ed. Philadelphia, PA: Elsevier; 2005:204-233.
5. Medeiros F, Corless CL, Duensing A, et al. KIT-negative gastrointestinal stromal tumors. Proof of concept and therapeutic implications. Am J Surg Path. 2004;28:889-894.
6. Miettinen M, Lasota J. KIT (CD117): A review on expression in normal and neoplastic tissues, and mutations and their clinic pathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205-220.
7. West RB, Corless CL, Chen X, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004;165:107-113.
8. Miwa S, Nakajima T, Murai Y, et al. Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs). J Gastroenterol. 2008;43:531-537.
9. Liegl B, Hornick JL, Corless CL, et al. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol. 2009;33:437-446.
10. Altman A, Villalba M. Protein kinase C-theta (PKC theta): It's all about location, location, location. Immunol Rev. 2003;192:53-63.
11. Motegi A, Sakurai S, Nakayama H, et al. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors. Pathol Int. 2005;55:106-112.
12. Blay P, Astudillo A, Buesa JM, et al. Protein kinase C y is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias. Clin Cancer Res. 2004;10(12 pt 1):4089-4095.
13. Lee HE, Kim MA, Lee HS, et al. Characteristics of Kitnegative gastrointestinal stromal tumors and diagnostic utility of protein kinase C theta immunostaining. J Clin Pathol. 2008;61:722-729.
14. Rudolph P, Chiaravalli AM, Pauser U, et al. Gastrointestinal mesenchymal tumors -immunophenotypic classification and survival analysis. Virchows Arch. 2002;441:238-248.
15. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: A clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000;24:211-222.
16. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577-580.
17. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299:708-710.
18. Spritz RA, Strunk KM, Lee ST, et al. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12. Genomics. 1994;22:431-436.
19. Hornick JL, Fletcher CD. Validating immunohistochemical staining for KIT (CD117). Am J Clin Pathol. 2003;119: 325-327.
20. Akahoshi K, Sumida Y, Matsui N, et al. Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration. World J Gastroenterol. 2007;13:2077-2082.
21. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347:472-480.
22. Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF. Gastrointestinal stromal tumors: Current diagnosis, biologic behavior, and management. Ann Surg Oncol. 2000;7:705-712.
23. Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck: An ancillary marker for adenoid cystic carcinoma. Mod Pathol. 2003;16: 1224-1231.
24. Ettl T, Schwarz S, Kleinsasser N, Hartmann A, Reichert TE, Driemel O. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology. 2008;53:567-577.
25. Schmitt AC, Cohen C, Siddiqui MT. Differential expression of 2 different dog-1 antibodies: Utility in detecting gastrointestinal stromal tumors. J Histotechnology. 2010;33:71-76.
26. Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors. A study of 1840 cases. Am J Surg Pathol. 2009;33:1401-1408.
27. Espinosa I, Lee CH, Kim MK, et al. A novel monoclonal antibody against DOG-1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol. 2008; 32:210-218.
28. Antonescu CR. Targeted therapies in gastrointestinal stromal tumors. Semin Diagn Pathol. 2008;25:295-303.
29. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol. 2004;22:3813-3825.
30. Lasota J, Miettinen M. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumors. Histopathology. 2008;53:245-266.
31. Takazawa Y, Sakurai S, Sakuma Y, et al. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease). Am J Surg Pathol. 2005;29:755-763.